(Total Views: 560)
Posted On: 10/25/2020 7:25:13 PM
Post# of 145247
Exactly. Even the most useless drugs can perform astonishingly well in open-label trials, but then do nothing in double-blind placebo-controlled studies.
The fact that remdesivir did NOTHING in a huge open-label study is therefore very very suspicious and alarming, since it throws shade on the studies previously conducted...
The fact that remdesivir did NOTHING in a huge open-label study is therefore very very suspicious and alarming, since it throws shade on the studies previously conducted...
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)